Combined CM and STN Stimulation for Motor Epilepsy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBoston Scientific Corporation

About this trial

This self-crossover, randomized controlled, pilot study aims to collect clinical data of bilateral stimulation of subthalamic nucleus (STN) combined with centromedian (CM) thalamus deep brain stimulation (DBS) for drug resistant epilepsy with motor symptom in adults.

Eligibility criteria

Qualifiers

1) 18-65 Years.

2) Drug Resistant Epilepsy.

Epilepsy diagnosis meeting ILAE criteria

4) >3 Focal or Generalized seizures / month with an inter-seizure interval no great than 30 days.

Disqualifiers

1) Non Motor Epilepsy.

2) Previous diagnosis of psychogenic/non-epileptic seizures.

3) Brain lesion resection or ablation surgery performed less than 6 months.

4) Implanted Vagus nerve stimulation (VNS) or responsive neurostimulation (RNS) devices recommended neither stimulation off the device at least 6 months nor remove the device.

Trial design

Treatments tested in this trial

  • Deep brain stimulation

Treatment groups

10 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators